Per Thayssen

Summary

Affiliation: Odense University Hospital
Country: Denmark

Publications

  1. doi The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation
    Per Thayssen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    EuroIntervention 8:591-8. 2012
  2. ncbi Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    EuroIntervention 5:898-905. 2010
  3. doi Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Am J Cardiol 109:629-35. 2012
  4. ncbi Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry
    Jesper Khedri Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Catheter Cardiovasc Interv 81:260-5. 2013
  5. ncbi 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry)
    Anne Kaltoft
    Department of Cardiology, Aarhus University Hospital, Skejby, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark
    J Am Coll Cardiol 53:658-64. 2009
  6. ncbi Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
    Evald Høj Christiansen
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    Lancet 381:661-9. 2013
  7. doi Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Catheter Cardiovasc Interv 75:101-8. 2010
  8. doi Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Sdr Boulevard 29, Odense, Denmark
    Circ Cardiovasc Interv 1:176-84. 2008
  9. doi Serial intravascular ultrasound analysis of peri-stent remodeling and proximal and distal edge effects after sirolimus-eluting or paclitaxel-eluting stent implantation in patients with diabetes mellitus
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark, USA
    Am J Cardiol 103:1083-8. 2009
  10. doi Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Eur Heart J 29:2733-41. 2008

Collaborators

Detail Information

Publications62

  1. doi The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation
    Per Thayssen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    EuroIntervention 8:591-8. 2012
    ..We examined the prognostic impact of stent thrombosis and in-stent restenosis in patients treated with percutaneous coronary intervention (PCI)...
  2. ncbi Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    EuroIntervention 5:898-905. 2010
    ..We examined the incidence of stent thrombosis and other outcomes in patients treated with PCI and paclitaxeleluting stents (PES), sirolimus-eluting stents (SES) or bare-metal stents (BMS)...
  3. doi Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Am J Cardiol 109:629-35. 2012
    ..03, 95% CI 1.59 to 2.59). In conclusion, stent thrombosis rate was similar in patients with and without DM and STEMI treated with primary PCI, whereas the presence of DM increased the risk of MI, TLR, and death...
  4. ncbi Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry
    Jesper Khedri Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Catheter Cardiovasc Interv 81:260-5. 2013
    ..We assessed the clinical presentation, the incidence, and prognosis of definite stent thrombosis or restenosis after DES implantation for treatment of restenosis...
  5. ncbi 2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry)
    Anne Kaltoft
    Department of Cardiology, Aarhus University Hospital, Skejby, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark
    J Am Coll Cardiol 53:658-64. 2009
    ..This registry study assessed the safety and efficacy of the 2 types of drug-eluting stents (DES), sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES), compared with bare-metal stents (BMS)...
  6. ncbi Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial
    Evald Høj Christiansen
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    Lancet 381:661-9. 2013
    ..We aimed to further investigate the effects of a biodegradable polymer biolimus-eluting stent compared with a durable polymer-coated sirolimus-eluting stent in a population-based setting...
  7. doi Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Catheter Cardiovasc Interv 75:101-8. 2010
    ..Background: PCI of left main coronary artery lesions may be an alternative to coronary artery bypass grafting in high-risk surgical patients...
  8. doi Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Sdr Boulevard 29, Odense, Denmark
    Circ Cardiovasc Interv 1:176-84. 2008
    ..Therefore, we examined the risk of target lesion revascularization (TLR), stent thrombosis, myocardial infarction, and death after the implantation of DES or BMS in primary PCI patients in Western Denmark...
  9. doi Serial intravascular ultrasound analysis of peri-stent remodeling and proximal and distal edge effects after sirolimus-eluting or paclitaxel-eluting stent implantation in patients with diabetes mellitus
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark, USA
    Am J Cardiol 103:1083-8. 2009
    ..These findings were not seen in Cypher stents...
  10. doi Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Eur Heart J 29:2733-41. 2008
    ..The aim of the study was to evaluate the extent and distribution of NIH with intravascular ultrasound (IVUS) after coronary artery stenting with sirolimus-eluting (Cypher) or paclitaxel-eluting (Taxus) stents in diabetic patients...
  11. ncbi Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    J Am Coll Cardiol 50:463-70. 2007
    ..The aim of the study was to examine outcomes subsequent to implantation of drug-eluting stents (DES) and bare-metal stents (BMS)...
  12. doi Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy)
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    Am J Cardiol 108:1232-7. 2011
    ..In conclusion, implantation of ZESs compared to SESs is associated with a considerable increased risk of adverse events in patients with diabetes at 18-month follow-up...
  13. ncbi Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 105:1513-9. 2010
    ..Drug-eluting stent treatment reduced the risk of target lesion revascularization compared to bare metal stent treatment, regardless of diabetes status...
  14. doi Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST-segment elevation myocardial infarction: from the Western Denmark heart registry
    Lisbeth Antonsen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Catheter Cardiovasc Interv 81:912-9. 2013
    ..Elderly patients with ST segment elevation myocardial infarction (STEMI) constitute a particular risk group in relation to primary percutaneous coronary intervention (PPCI)...
  15. doi Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby Hospital, Aarhus, Denmark
    Am J Cardiol 103:345-9. 2009
    ..19). In conclusion, angiographic in-stent late luminal loss is significantly reduced in patients with diabetes by use of the sirolimus-eluting Cypher stent compared with the paclitaxel-eluting Taxus stent...
  16. doi Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial
    Klaus Rasmussen
    Department of Cardiology, Aarhus University Hospital, Aalborg Hospital, Aalborg, Denmark
    Lancet 375:1090-9. 2010
    ..We compared the efficacy and safety of the zotarolimus-eluting stent versus the sirolimus-eluting stent in patients with coronary artery disease who were receiving routine clinical care with no direct follow-up...
  17. ncbi Intravascular ultrasound assessment of expansion of the sirolimus-eluting (cypher select) and paclitaxel-eluting (Taxus Express-2) stent in patients with diabetes mellitus
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 102:19-26. 2008
    ..Cypher Select stent and insulin treatment were independent predictors of not achieving a minimum stent area >5.0 mm2...
  18. doi Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    Circulation 125:1246-55. 2012
    ..Among drug-eluting stents released to date, the sirolimus-eluting stent has demonstrated the least amount of late lumen loss, but its efficacy and safety have not been compared head-to-head with the next-generation everolimus-eluting stent...
  19. doi Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy
    Troels Thim
    Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
    Eur J Clin Invest 42:1047-54. 2012
    ..To compare clinical outcomes among patients with acute coronary syndrome treated with zotarolimus-eluting and sirolimus-eluting stents in the SORT OUT III trial...
  20. doi 2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    J Am Coll Cardiol 60:1140-7. 2012
    ..There are limited head-to-head randomized data on patient-related versus stent-related outcomes for everolimus-eluting stents (EES) and sirolimus-eluting stents (SES)...
  21. doi Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial)
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 110:1585-91. 2012
    ..In conclusion, patients with diabetes have higher MACE rates than nondiabetics. No significant differences in safety or efficacy outcomes after EES or SES implantation were present in nondiabetic or diabetic patients...
  22. doi Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction)
    Lisbeth Antonsen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 108:1395-400. 2011
    ..Patients with SAP had the lowest mortality rates and rates of clinically driven target vessel revascularization decreased over time...
  23. pmc Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark
    BMC Cardiovasc Disord 12:84. 2012
    ..We evaluated the effectiveness and safety of a zotarolimus-eluting (ZES) versus a sirolimus-eluting (SES) coronary stent in a large cohort of patients treated with one of these stents in Western Denmark...
  24. doi Comparison of intravascular ultrasound and angiographic assessment of coronary reference segment size in patients with type 2 diabetes mellitus
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 101:590-5. 2008
    ..In conclusion, these findings combined with inadequate remodeling may explain the angiographic appearance of small arteries in diabetic patients...
  25. pmc Can preoperative myocardial perfusion scintigraphy predict changes in left ventricular perfusion and function after coronary artery bypass graft surgery?
    Rozy Eckardt
    Department of Cardiothoracic Surgery, Institute of Clinical Research, Odense University Hospital, Odense, Denmark
    Interact Cardiovasc Thorac Surg 14:779-84. 2012
    ..Normal perfusion is obtained almost exclusively in territories with reversible ischaemia. Symptoms improved in nearly all patients and LVEF in a significant fraction of the patients, not related to preoperative MPS...
  26. doi Culprit only or multivessel percutaneous coronary interventions in patients with ST-segment elevation myocardial infarction and multivessel disease
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Denmark
    EuroIntervention 8:456-64. 2012
    ..However, it remains unclear whether the optimal strategy is complete revascularisation or culprit vessel PPCI only...
  27. ncbi Influence of a pressure gradient distal to implanted bare-metal stent on in-stent restenosis after percutaneous coronary intervention
    Lisette Okkels Jensen
    Department of Cardiology, Catheterization Laboratory, Odense University Hospital, Sdr Blvd 29, 5000 Odense C, Denmark
    Circulation 116:2802-8. 2007
    ....
  28. doi Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience v/Promus) and sirolimus-eluting (cypher select+) coronary stents in unselected patients with coronary heart disease
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Cardiology 116:73-8. 2010
    ..The sirolimus-eluting stent has demonstrated the least amount of late lumen loss among previously released drug-eluting stents, but its safety and efficacy has not been compared head-to-head with the everolimus-eluting stent...
  29. doi Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    EuroIntervention 7:323-31. 2011
    ....
  30. pmc Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
    Troels Thim
    Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
    BMC Cardiovasc Disord 12:18. 2012
    ..However, a separate comparison of clinical outcome among patients treated for multiple lesions with these stents is lacking. We performed this comparison within the SORT OUT III trial data set...
  31. ncbi Influence of high-dose lipid lowering treatment compared to low-dose lipid lowering treatment on plaque composition assessed by intravascular ultrasound virtual histology in patients with ST-segment elevation acute myocardial infarction: the VIRHISTAMI tr
    Rasmus Egede
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    EuroIntervention 8:1182-9. 2013
    ....
  32. ncbi Long-term effects of invasive treatment in patients with a post-thrombolytic Q-wave myocardial infarction
    Klaus F Kofoed
    Department of Cardiology, The Heart Centre, Rigshospitalet, Copenhagen, Denmark
    Scand Cardiovasc J 44:146-52. 2010
    ..The aim of the present study was to assess the effect of a deferred invasive treatment strategy on long-term outcome in patients with a post-thrombolytic Q-wave myocardial infarction and inducible myocardial ischemia...
  33. doi Clinical reinfarction according to infarct location and reperfusion modality in patients with ST elevation myocardial infarction. A DANAMI-2 long-term follow-up substudy
    Martin Busk
    Department of Cardiology, Aarhus University Hospital Skejby, Aarhus, Denmark
    Cardiology 113:72-80. 2009
    ..To evaluate clinical reinfarction during a 3-year follow-up after randomization to primary angioplasty versus fibrinolysis in anterior and non-anterior ST elevation myocardial infarction (STEMI)...
  34. ncbi Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized diabetes and drug-eluting stent (DiabeDES) IV intravascular ultrasound trial
    Lisbeth Antonsen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Catheter Cardiovasc Interv 83:864-72. 2014
    ..To evaluate the effects of the everolimus-eluting Xience™/Promus™ stent (EES) and the sirolimus-eluting Cypher™ stent (SES) on intimal hyperplasia (IH) in diabetic patients...
  35. ncbi Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients
    Lisette Okkels Jensen
    Catheterization Laboratory, Department of Cardiology, Odense University Hospital, Odense C, Denmark
    Eur Heart J 28:1759-64. 2007
    ..The aim was to assess lesion and reference segment remodelling and plaque burden in patients with type-2 diabetes mellitus...
  36. doi 3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
    JACC Cardiovasc Interv 5:812-8. 2012
    ....
  37. doi Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus
    Michael Maeng
    Department of Cardiology, Skejby Sygehus, Aarhus University Hospital, Aarhus, Denmark
    Am J Cardiol 102:165-72. 2008
    ..In conclusion, use of DESs reduced target-lesion revascularization in diabetic patients receiving routine clinical care. This result was obtained without increased risk of death, stent thrombosis, or MI...
  38. pmc Target lesion revascularisation in patients treated with a sirolimus-eluting or paclitaxel-eluting stent
    Michael Maeng
    Department of Cardiology, Skejby Sygehus, Aarhus University Hospital, Aarhus, Denmark
    Heart 93:694-7. 2007
    ..To identify risk factors for clinical-driven target lesion revascularisation (TLR) in patients treated with sirolimus-eluting (Cypher) or paclitaxel-eluting (Taxus) stents in a real-world scenario...
  39. doi System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial)
    Peter H Nielsen
    Department of Cardiology, Aarhus University Hospital, Skejby, Denmark
    Am J Cardiol 108:776-81. 2011
    ..pPCI performed with a system delay of <2 hours is associated with lower mortality than fibrinolysis performed with a faster or similar system delay...
  40. doi Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients
    Rasmus Egede
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Int J Cardiol 158:376-9. 2012
    ....
  41. ncbi Hybrid CT angiography and quantitative 15O-water PET for assessment of coronary artery disease: comparison with quantitative coronary angiography
    Anders Thomassen
    Department of Nuclear Medicine, OUH, Odense University Hospital, Sdr Boulevard 29, 5000, Odense C, Denmark
    Eur J Nucl Med Mol Imaging 40:1894-904. 2013
    ..Therefore, a combination of the two might improve diagnostic accuracy. We conducted a head-to-head comparison of CTA, measurement of MBF by (15)O-water PET, and hybrid PET/CTA for the detection of significant coronary artery stenoses...
  42. doi Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial
    Anders M Galløe
    Department of Cardiology, Gentofte University Hospital, Hellerup, Copenhagen, Denmark
    JAMA 299:409-16. 2008
    ..Approval of drug-eluting coronary stents was based on results of relatively small trials of selected patients; however, in routine practice, stents are used in a broader spectrum of patients...
  43. ncbi Effect of simvastatin on coronary lesion site remodeling: a serial intravascular ultrasound study
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Cardiology 106:256-63. 2006
    ..The aim of the study was to assess the effect of simvastatin on coronary remodeling in serial intravascular ultrasound (IVUS) studies...
  44. doi Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease
    Aziza Azimi
    Department of Cardiology, Gentofte Hospital, Post 635, Niels Andersens Vej 65, Hellerup 2900, Denmark
    Heart 99:655-60. 2013
    ..We explored this paradox further by examining the influence of obesity on survival in patients with verified atherosclerotic heart disease...
  45. ncbi Changes in left ventricular filling patterns after repeated injection of autologous bone marrow cells in heart failure patients
    Axel C P Diederichsen
    Department of Cardiology, Odense University Hospital, Denmark
    Scand Cardiovasc J 44:139-45. 2010
    ..However, the impact of BMSC therapy on LV diastolic filling has remained uncertain...
  46. doi Diagnostic value of cardiac 64-slice computed tomography: importance of coronary calcium
    Axel C P Diederichsen
    Department of Cardiology, Odense University Hospital, Denmark
    Scand Cardiovasc J 43:337-44. 2009
    ..However, coronary calcium can reduce its diagnostic value. The objective of this study was to define a calcium score above which CTA appears less reliable...
  47. ncbi Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry
    Mikkel Hougaard
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Catheter Cardiovasc Interv 83:1035-42. 2014
    ..We used the Western Denmark Heart Registry to assess one-year and long-term all-cause mortality and stent failure following Percutaneous Coronary Intervention (PCI) with drug-eluting stents (DES) or bare-metal stents (BMS)...
  48. ncbi Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial
    Per Thayssen
    From the Department of Cardiology, Odense University Hospital, Odense, Denmark P T, K N H, H S H, A J, K T V, L O J Department of Cardiology, Aarhus University Hospital, Skejby, Denmark J F L, E H C, L T and Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark S E J, J R
    Circ Cardiovasc Interv 7:216-24. 2014
    ..We compared the risk of acute CIN and the influence of preventive strategies in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention...
  49. doi Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results
    Michael Maeng
    Department of Cardiology, Aarhus University Hospital, Skejby, Denmark
    J Am Coll Cardiol 62:30-4. 2013
    ..This study sought to report the 5-year follow-up results of the Nordic Bifurcation Study...
  50. ncbi Recruitable collateral blood flow index predicts coronary instent restenosis after percutaneous coronary intervention
    Lisette Okkels Jensen
    Department of Cardiology, Catheterization Laboratory, Odense University Hospital, Sdr Boulevard 29, 5000 Odense C, Denmark
    Eur Heart J 28:1820-6. 2007
    ..The aim of the study was to assess the influence of recruitable collateral blood flow on restenosis in patients undergoing PCI with bare metal stents and using optimal antithrombotic treatment...
  51. ncbi Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial
    Lisbeth Antonsen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    EuroIntervention 10:212-23. 2014
    ..81, 95% CI: 0.54-1.22) nor between SAP patients treated with EES or SES (6.9% versus 6.5%; HR=1.05, 95% CI: 0.71-1.55). Conclusions: EES and SES performed similarly with respect to MACE at 18-month follow-up in patients with ACS and SAP. ..
  52. ncbi The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up
    Martin Busk
    Department of Cardiology, Aarhus University Hospital Skejby, Brendstrupgaardsvej 100, DK 8200 Aarhus N, Denmark
    Eur Heart J 29:1259-66. 2008
    ..This paper reports on the pre-specified long-term composite endpoint at 3 years follow-up in DANAMI-2...
  53. ncbi Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents
    Niels Bligaard
    Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
    Scand Cardiovasc J 48:148-55. 2014
    ..Therefore, the long-term outcome follow-up is of major clinical interest...
  54. ncbi Accuracy of electrocardiographic-gated versus nongated volumetric intravascular ultrasound measurements of coronary arterial narrowing
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am J Cardiol 99:279-83. 2007
    ..18 +/- 3.42 vs -0.74 +/- 3.88 mm(3), p = NS). In conclusion, in moderate atherosclerotic or stented coronary arteries, electrocardiographically gated IVUS acquisition is not superior in accuracy to conventional nongated IVUS acquisition...
  55. ncbi Safety in simple versus complex stenting of coronary artery bifurcation lesions. The nordic bifurcation study 14-month follow-up results
    Jan S Jensen
    Department of Cardiology, Gentofte University Hospital, Gentofte, Denmark
    EuroIntervention 4:229-33. 2008
    ..The present study reports the pre-specified secondary endpoint of a 14-month stent thrombosis and major adverse cardiac events in patients stented with a simple versus a complex bifurcation technique using sirolimus eluting stents (SES)...
  56. pmc Impact of renal insufficiency on mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
    Jonas Emil Sabroe
    Department of Cardiology, Odense University Hospital, SDR, Boulevard 29, 5000 Odense, Denmark
    BMC Cardiovasc Disord 14:15. 2014
    ....
  57. ncbi Effect of simvastatin on coronary flow reserve in patients with atherosclerosis and hypercholesterolemia: an intracoronary Doppler study
    Lisette O Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Coron Artery Dis 17:51-6. 2006
    ..Reduced coronary flow reserve has been reported in patients with hypercholesterolemia, despite angiographically normal coronary arteries. The aim of the study was to evaluate the effect of simvastatin on coronary flow reserve...
  58. doi Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure the Danish stem cell study--congestive heart failure trial (DanCell-CHF)
    Axel C P Diederichsen
    Department of Cardiology, Odense University Hospital, Denmark
    Eur J Heart Fail 10:661-7. 2008
    ..The effect is uncertain in patients with chronic ischaemic heart failure and it is not known whether repeated infusions would have additional positive effects...
  59. doi Outcome and safety of same-day-discharge percutaneous coronary interventions with femoral access: a single-center experience
    Lisbeth Antonsen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Am Heart J 165:393-9. 2013
    ..We examined the safety and outcome in low-risk patients discharged the same day as PCI with femoral access was performed...
  60. ncbi Frequent change of procedure during coronary artery bypass surgery suggests insufficient preoperative diagnostic strategy
    Rozy Eckardt
    Department of Cardiothoracic Surgery, Institute of Clinical Research, Odense University Hospital, 5000 Odense C, Denmark
    Interact Cardiovasc Thorac Surg 6:298-302. 2007
    ..037). Our findings might indicate the necessity of future studies with the use of scintigraphy or fractional flow reserve as physiological adjuncts to angiography for more targeted revascularization...
  61. ncbi Target vessel revascularization following percutaneous coronary intervention. A 10-year report from the Danish Percutaneous Transluminal Coronary Angioplasty Registry
    Lisette Okkels Jensen
    Department of Cardiology, Odense University Hospital, Odense, Denmark
    Scand Cardiovasc J 39:30-5. 2005
    ..To present the rate of target vessel revascularization (TVR) in a consecutive and unselected national population over 10 years...
  62. ncbi Short- and long-term influence of diet and simvastatin on brachial artery endothelial function
    Lisette Okkels Jensen
    Department of Cardiology, Catheterization Laboratory, Odense University Hospital, Sdr Boulevard 29, DK 5000, Odense, Denmark
    Int J Cardiol 107:101-6. 2006
    ..The aim of the study was to assess the short-term effect of diet as well as short- and long-term effect of simvastatin on EDD in patients with hypercholesterolemia and ischemic heart disease...